Literature DB >> 27350737

miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.

Gui-Xi Zheng1, Ai-Lin Qu1, Yong-Mei Yang1, Xin Zhang1, Shou-Cai Zhang1, Chuan-Xin Wang1.   

Abstract

AIM: To determine the expression of miR-422a in colorectal cancer (CRC) tissues and to further explore the prognostic value and function of miR-422a in CRC carcinogenesis.
METHODS: miR-422a expression was analyzed in 102 CRC tissues and paired normal mucosa adjacent to carcinoma by quantitative real-time PCR. The relationship of miR-422a expression with clinicopathological parameters was also analyzed. Kaplan-Meier analysis and Cox multivariate analysis were performed to estimate the potential role of miR-422a. Cell proliferation, migration, and invasion were used for in vitro functional analysis of miR-422a.
RESULTS: The levels of miR-422a were dramatically reduced in CRC tissues compared with normal mucosa (P < 0.05), and significantly correlated with local invasion (P = 0.004) and lymph node metastasis (P < 0.001). Kaplan-Meier survival and Cox regression multivariate analyses revealed that miR-422a expression (HR = 0.568, P = 0.015) and clinical TNM stage (HR = 2.942, P = 0.003) were independent prognostic factors for overall survival in CRC patients. Furthermore, in vitro experiments showed that overexpression of miR-422a inhibited the proliferation, migration, and invasion of SW480 and HT-29 cells.
CONCLUSION: Down-regulation of miR-422a may serve as an independent prognosis factor in CRC. MiR-422a functions as a tumor suppressor and regulates progression of CRC.

Entities:  

Keywords:  Colorectal cancer; In vitro function; MicroRNA; Prognosis; miR-422a

Mesh:

Substances:

Year:  2016        PMID: 27350737      PMCID: PMC4917619          DOI: 10.3748/wjg.v22.i24.5589

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Modulation of microRNA processing by mismatch repair protein MutLα.

Authors:  Guogen Mao; Sanghee Lee; Janice Ortega; Liya Gu; Guo-Min Li
Journal:  Cell Res       Date:  2012-01-31       Impact factor: 25.617

2.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

Authors:  Fatima A Haggar; Robin P Boushey
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 3.  MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.

Authors:  Nowroji Kavitha; Soundararajan Vijayarathna; Subramanion Lachumy Jothy; Chern Ein Oon; Yeng Chen; Jagat Rakesh Kanwar; Sreenivasan Sasidharan
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Circulating microRNAs involved in multiple sclerosis.

Authors:  Sue Rutherford Siegel; Jason Mackenzie; George Chaplin; Nina G Jablonski; Lyn Griffiths
Journal:  Mol Biol Rep       Date:  2012-01-10       Impact factor: 2.316

5.  MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.

Authors:  Juan Li; Lutao Du; Yongmei Yang; Chuanxin Wang; Hui Liu; Lili Wang; Xin Zhang; Wei Li; Guixi Zheng; Zhaogang Dong
Journal:  Cancer Lett       Date:  2012-10-27       Impact factor: 8.679

6.  MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer.

Authors:  Jinfeng Wang; Xin Zhang; Lili Wang; Yongmei Yang; Zhaogang Dong; Haiyan Wang; Lutao Du; Chuanxin Wang
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.

Authors:  G Zheng; L Du; X Yang; X Zhang; L Wang; Y Yang; J Li; C Wang
Journal:  Br J Cancer       Date:  2014-09-18       Impact factor: 7.640

8.  Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.

Authors:  Mohamed Abdel-Mohsen; Xutao Deng; Ali Danesh; Teri Liegler; Evan S Jacobs; Andri Rauch; Bruno Ledergerber; Philip J Norris; Huldrych F Günthard; Joseph K Wong; Satish K Pillai
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

9.  Epigenetics and colorectal cancer pathogenesis.

Authors:  Kankana Bardhan; Kebin Liu
Journal:  Cancers (Basel)       Date:  2013-06-05       Impact factor: 6.639

10.  MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis.

Authors:  Zheng Cao; Benjamin T Moore; Yang Wang; Xian-Hao Peng; Joan M Lappe; Robert R Recker; Peng Xiao
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more
  12 in total

1.  The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies.

Authors:  Agnieszka Piechowska; Celina Kruszniewska-Rajs; Magdalena Kimsa-Dudek; Magdalena Kołomańska; Barbara Strzałka-Mrozik; Joanna Gola; Stanisław Głuszek
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-15       Impact factor: 4.553

2.  miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.

Authors:  Zujian Chen; Tianwei Yu; Robert J Cabay; Yi Jin; Ishrat Mahjabeen; Xianghong Luan; Lei Huang; Yang Dai; Xiaofeng Zhou
Journal:  Biomark Cancer       Date:  2017-01-09

3.  Long intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer.

Authors:  Shao-Ping Zhu; Jun-Yu Wang; Xian-Guo Wang; Jin-Ping Zhao
Journal:  Aging (Albany NY)       Date:  2017-02-06       Impact factor: 5.682

4.  miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS.

Authors:  Hao Zhang; Qian-Yun He; Guang-Chao Wang; Da-Ke Tong; Ren-Kai Wang; Wen-Bin Ding; Cheng Li; Qiang Wei; Chen Ding; Pei-Zhao Liu; Hao-Chen Cui; Xin Zhang; Di Li; Hao Tang; Fang Ji
Journal:  Biosci Rep       Date:  2018-03-21       Impact factor: 3.840

5.  The Long Noncoding RNA D63785 Regulates Chemotherapy Sensitivity in Human Gastric Cancer by Targeting miR-422a.

Authors:  Zhixia Zhou; Zhijuan Lin; Yuqi He; Xin Pang; Yin Wang; Murugavel Ponnusamy; Xiang Ao; Peipei Shan; Muhammad Akram Tariq; Peifeng Li; Jianxun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-05       Impact factor: 8.886

6.  Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans.

Authors:  Ailin Qu; Yongmei Yang; Xin Zhang; Wenfei Wang; Yingjie Liu; Guixi Zheng; Lutao Du; Chuanxin Wang
Journal:  EBioMedicine       Date:  2018-10-09       Impact factor: 8.143

7.  A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.

Authors:  Jiajia Feng; Qinyi Zhou; Hongliang Yi; Shiyin Ma; Dawei Li; Yanan Xu; Jiadong Wang; Shankai Yin
Journal:  Cell Death Dis       Date:  2019-06-03       Impact factor: 8.469

8.  MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer.

Authors:  Zhongyuan He; Zheng Li; Xuan Zhang; Kai Yin; Weizhi Wang; Zhipeng Xu; Bowen Li; Lei Zhang; Jianghao Xu; Guangli Sun; Lu Wang; Qing Li; Xiaoxu Huang; Lu Zhang; Diancai Zhang; Hao Xu; Zekuan Xu
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

9.  Prognostic value of microRNAs in colorectal cancer: a meta-analysis.

Authors:  Song Gao; Zhi-Ying Zhao; Rong Wu; Yue Zhang; Zhen-Yong Zhang
Journal:  Cancer Manag Res       Date:  2018-04-30       Impact factor: 3.989

10.  miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.

Authors:  Wen-Ting Wei; Xin-Xin Nian; Shu-Yang Wang; Hong-Li Jiao; Yong-Xia Wang; Zhi-Yuan Xiao; Run-Wei Yang; Yan-Qing Ding; Ya-Ping Ye; Wen-Ting Liao
Journal:  Cancer Cell Int       Date:  2017-10-28       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.